Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Amy Yule, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone SV, Franck J, González RA, Grau-López L, Groenman AP, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan JG, Kaye SS, Kiefer F, Konstenius M, Levin FR, Luderer M, Martinotti G, Matthys FIA, Meszaros G, Moggi F, Munasur-Naidoo AP, Post M, Rabinovitz S, Ramos-Quiroga JA, Sala R, Shafi A, Slobodin O, Staal WG, Thomasius R, Truter I, van Kernebeek MW, Velez-Pastrana MC, Vollstädt-Klein S, Vorspan F, Young JT, Yule A, van den Brink W, Hendriks V. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. Z Kinder Jugendpsychiatr Psychother. 2021 Aug 16. PMID: 34397296.
    Citations:    Fields:    
  2. Yule AM, DiSalvo M, Biederman J, Wilens TE, Dallenbach NT, Taubin D, Joshi G. Decreased risk for substance use disorders in individuals with high-functioning autism spectrum disorder. Eur Child Adolesc Psychiatry. 2021 Aug 07. PMID: 34363537.
    Citations:    Fields:    
  3. Yule AM, Ijadi-Maghsoodi R, Bagot KS, Bath E. Support for Early-Career Female Physician-Scientists as Part of the COVID-19 Recovery Plan. Acad Med. 2021 May 01; 96(5):e16-e17. PMID: 33315597.
    Citations:    Fields:    Translation:HumansPHPublic Health
  4. Bentley KH, Sakurai H, Lowman KL, Rines-Toth L, McKowen J, Pedrelli P, Evins AE, Yule AM. Validation of brief screening measures for depression and anxiety in young people with substance use disorders. J Affect Disord. 2021 03 01; 282:1021-1029. PMID: 33601674.
    Citations:    Fields:    Translation:HumansPHPublic Health
  5. Xuan Z, Choi J, Lobrutto L, Cunningham T, Castedo de Martell S, Cance J, Silverstein M, Yule AM, Botticelli M, Holleran Steiker L. Support Services for Young Adults With Substance Use Disorders. Pediatrics. 2021 01; 147(Suppl 2):S220-S228. PMID: 33386325.
    Citations:    Fields:    Translation:Humans
  6. Spencer AE, Valentine SE, Sikov J, Yule AM, Hsu H, Hallett E, Xuan Z, Silverstein M, Fortuna L. Principles of Care for Young Adults With Co-Occurring Psychiatric and Substance Use Disorders. Pediatrics. 2021 01; 147(Suppl 2):229-239. PMID: 33386320.
    Citations:    Fields:    Translation:Humans
  7. Hadland SE, Yule AM, Levy SJ, Hallett E, Silverstein M, Bagley SM. Evidence-Based Treatment of Young Adults With Substance Use Disorders. Pediatrics. 2021 01; 147(Suppl 2):S204-S214. PMID: 33386323.
    Citations:    Fields:    Translation:Humans
  8. Yule AM, DiSalvo M, Wilens TE, Wozniak J, Faraone SV, Lyons RM, Woodworth KY, Biederman J. High Correspondence Between Child Behavior Checklist Rule Breaking Behavior Scale with Conduct Disorder in Males and Females. Child Psychiatry Hum Dev. 2020 12; 51(6):978-985. PMID: 32172405.
    Citations:    Fields:    Translation:Humans
  9. Bagley SM, Hadland SE, Yule AM. A commentary on the impact of COVID-19 on engagement of youth with substance use and co-occurring psychiatric disorders. J Subst Abuse Treat. 2021 02; 121:108175. PMID: 33127195.
    Citations:    Fields:    Translation:Humans
  10. Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone SV, Franck J, González RA, Grau-López L, Groenman AP, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan JG, Kaye SS, Kiefer F, Konstenius M, Levin FR, Luderer M, Martinotti G, Matthys FIA, Meszaros G, Moggi F, Munasur-Naidoo AP, Post M, Rabinovitz S, Ramos-Quiroga JA, Sala R, Shafi A, Slobodin O, Staal WG, Thomasius R, Truter I, van Kernebeek MW, Velez-Pastrana MC, Vollstädt-Klein S, Vorspan F, Young JT, Yule A, van den Brink W, Hendriks V. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. Eur Addict Res. 2020; 26(4-5):223-232. PMID: 32634814.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  11. Wilens TE, Martelon M, Yule A, Kaminski TA, Burke C, Schepis TS, McCabe SE. Disentangling the Social Context of Nonmedical Use of Prescription Stimulants in College Students. Am J Addict. 2020 11; 29(6):476-484. PMID: 32436300.
    Citations: 1     Fields:    Translation:Humans
  12. Schiff DM, Nielsen T, Terplan M, Wakeman SE, Yule AM, Mehta PK, Taveras EM, Wilens TE. IMPROVING MEASURES OF DYADIC OUTCOMES IN PERINATAL SUBSTANCE USE RESEARCH. Addiction. 2020 09; 115(9):1787-1788. PMID: 32143238.
    Citations:    Fields:    Translation:Humans
  13. Joshi G, DiSalvo M, Wozniak J, Ceranoglu TA, Yule A, Surman C, Fried R, Galdo M, Hoskova B, Belser A, Biederman J. A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder. World J Biol Psychiatry. 2020 04; 21(4):274-290. PMID: 31607204.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  14. Isenberg BM, Yule AM, McKowen JW, Nowinski LA, Forchelli GA, Wilens TE. Considerations for Treating Young People With Comorbid Autism Spectrum Disorder and Substance Use Disorder. J Am Acad Child Adolesc Psychiatry. 2019 12; 58(12):1139-1141. PMID: 31757396.
    Citations: 2     Fields:    Translation:Humans
  15. Nielsen T, Bernson D, Terplan M, Wakeman SE, Yule AM, Mehta PK, Bharel M, Diop H, Taveras EM, Wilens TE, Schiff DM. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery. Addiction. 2020 02; 115(2):291-301. PMID: 31692133.
    Citations: 6     Fields:    Translation:Humans
  16. Beckmann D, Lowman KL, Nargiso J, McKowen J, Watt L, Yule AM. Substance-induced Psychosis in Youth. Child Adolesc Psychiatr Clin N Am. 2020 01; 29(1):131-143. PMID: 31708042.
    Citations:    Fields:    Translation:Humans
  17. Yule AM, Carrellas NW, DiSalvo M, Lyons RM, McKowen JW, Nargiso JE, Bergman BG, Kelly JF, Wilens TE. Risk Factors for Overdose in Young People Who Received Substance Use Disorder Treatment. Am J Addict. 2019 09; 28(5):382-389. PMID: 31291042.
    Citations: 1     Fields:    Translation:Humans
  18. Ameral V, Yule A, McKowen J, Bergman BG, Nargiso J, Kelly JF. A Naturalistic Evaluation of a Group Intervention for Parents of Youth with Substance Use Disorders. Alcohol Treat Q. 2020; 38(3):379-394. PMID: 32863559.
    Citations:    
  19. Lyons RM, Yule AM, Schiff D, Bagley SM, Wilens TE. Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature. J Child Adolesc Psychopharmacol. 2019 08; 29(7):487-497. PMID: 31246496.
    Citations: 5     Fields:    Translation:Humans
  20. Yule A, Fitzgerald M, Wilens T, Wozniak J, Woodworth KY, Pulli A, Uchida M, Faraone SV, Biederman J. Further Evidence of the Diagnostic Utility of the Child Behavior Checklist for Identifying Pediatric Bipolar I Disorder. Scand J Child Adolesc Psychiatr Psychol. 2019; 7(1):29-36. PMID: 32995342.
    Citations: 2     
  21. Yule AM, Levin FR. Supporting Providers After Drug Overdose Death. Am J Psychiatry. 2019 03 01; 176(3):173-178. PMID: 30818987.
    Citations: 1     Fields:    Translation:Humans
  22. Surman C, Ceranoglu A, Vaudreuil C, Albright B, Uchida M, Yule A, Spencer A, Boland H, Grossman R, Rhodewalt L, Fitzgerald M, Biederman J. Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical Trial. J Clin Psychopharmacol. 2019 Jan/Feb; 39(1):28-38. PMID: 30566416.
    Citations:    Fields:    Translation:Humans
  23. Yule AM, Kelly JF. Integrating Treatment for Co-Occurring Mental Health Conditions. Alcohol Res. 2019 10 24; 40(1). PMID: 31649837.
    Citations: 1     Fields:    Translation:Humans
  24. Biederman J, Fitzgerald M, Woodworth KY, Yule A, Noyes E, Biederman I, Faraone SV, Wilens T, Wozniak J. Does the course of manic symptoms in pediatric bipolar disorder impact the course of conduct disorder? Findings from four prospective datasets. J Affect Disord. 2018 10 01; 238:244-249. PMID: 29890451.
    Citations:    Fields:    Translation:Humans
  25. Yule AM, Carrellas NW, Fitzgerald M, McKowen JW, Nargiso JE, Bergman BG, Kelly JF, Wilens TE. Risk Factors for Overdose in Treatment-Seeking Youth With Substance Use Disorders. J Clin Psychiatry. 2018 May/Jun; 79(3). PMID: 29701935.
    Citations: 5     Fields:    Translation:Humans
  26. Yule AM, Lyons RM, Wilens TE. Opioid Use Disorders in Adolescents-Updates in Assessment and Management. Curr Pediatr Rep. 2018 Jun; 6(2):99-106. PMID: 30895165.
    Citations: 5     
  27. Yule AM, Wilens TE, Martelon M, Rosenthal L, Biederman J. Does exposure to parental substance use disorders increase offspring risk for a substance use disorder? A longitudinal follow-up study into young adulthood. Drug Alcohol Depend. 2018 05 01; 186:154-158. PMID: 29573650.
    Citations: 3     Fields:    Translation:Humans
  28. Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Feinberg L, Kassabian S, Storch B, Biederman J. The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone. J Clin Psychiatry. 2018 Mar/Apr; 79(2). PMID: 29617066.
    Citations:    Fields:    Translation:Humans
  29. Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Biederman J. Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone. J Clin Psychiatry. 2018 Jan/Feb; 79(1). PMID: 28640990.
    Citations:    Fields:    Translation:Humans
  30. Yule AM, Kelly JF. Recovery high schools may be a key component of youth recovery support services. Am J Drug Alcohol Abuse. 2018; 44(2):141-142. PMID: 29048934.
    Citations: 1     Fields:    Translation:Humans
  31. Wilens TE, Carrellas NW, Zulauf C, Yule AM, Uchida M, Spencer A, Biederman J. Pilot Data Supporting Omega-3 Fatty Acids Supplementation in Medicated Children with Attention-Deficit/Hyperactivity Disorder and Deficits in Emotional Self-Regulation. J Child Adolesc Psychopharmacol. 2017 10; 27(8):755-756. PMID: 28661708.
    Citations:    Fields:    Translation:Humans
  32. Yule AM, Wilens TE, Rauch PK. The Opioid Epidemic: What Is a Child Psychiatrist to Do? J Am Acad Child Adolesc Psychiatry. 2017 07; 56(7):541-543. PMID: 28647004.
    Citations:    Fields:    Translation:HumansPHPublic Health
  33. Wilens TE, Carrellas NW, Martelon M, Yule AM, Fried R, Anselmo R, McCabe SE. Neuropsychological functioning in college students who misuse prescription stimulants. Am J Addict. 2017 Jun; 26(4):379-387. PMID: 28494131.
    Citations: 10     Fields:    Translation:Humans
  34. Yule AM, Martelon M, Faraone SV, Carrellas N, Wilens TE, Biederman J. Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis. J Psychiatr Res. 2017 02; 85:49-55. PMID: 27835739.
    Citations: 5     Fields:    Translation:Humans
  35. Wilens TE, Biederman J, Martelon M, Zulauf C, Anderson JP, Carrellas NW, Yule A, Wozniak J, Fried R, Faraone SV. Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder. J Clin Psychiatry. 2016 Oct; 77(10):1420-1427. PMID: 27574842.
    Citations: 7     Fields:    Translation:Humans
  36. Wilens T, Zulauf C, Martelon M, Morrison NR, Simon A, Carrellas NW, Yule A, Anselmo R. Nonmedical Stimulant Use in College Students: Association With Attention-Deficit/Hyperactivity Disorder and Other Disorders. J Clin Psychiatry. 2016 07; 77(7):940-7. PMID: 27464314.
    Citations: 10     Fields:    Translation:Humans
  37. Wilens TE, Yule A, Martelon M, Zulauf C, Faraone SV. Parental history of substance use disorders (SUD) and SUD in offspring: a controlled family study of bipolar disorder. Am J Addict. 2014 Sep-Oct; 23(5):440-6. PMID: 24628811.
    Citations: 3     Fields:    Translation:Humans
  38. Yule AM, Wilens TE, Martelon MK, Simon A, Biederman J. Does exposure to parental substance use disorders increase substance use disorder risk in offspring? A 5-year follow-up study. Am J Addict. 2013 Sep-Oct; 22(5):460-5. PMID: 23952891.
    Citations: 23     Fields:    Translation:Humans
  39. Yule AM, Prince JB. Adolescent substance use disorders in the school setting. Child Adolesc Psychiatr Clin N Am. 2012 Jan; 21(1):175-86, xi. PMID: 22137820.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  40. Freeman MP, Hibbeln JR, Silver M, Hirschberg AM, Wang B, Yule AM, Petrillo LF, Pascuillo E, Economou NI, Joffe H, Cohen LS. Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial. Menopause. 2011 Mar; 18(3):279-84. PMID: 21037490.
    Citations: 13     Fields:    Translation:Humans
  41. Yule, Amy. Increased Soft Drink Consumption is Contributing to an Increased Incidence of Obesity. Nutrition Bytes. 2002; 8(1):3-6.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Yule's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (148)
Explore
_
Co-Authors (34)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.